Ascend Capital’s Aravive, Inc. Common Stock ARAV Stock Holding History

Ascend Capital’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$783K	Sell	93,239 -3,225	-3%	-$34K	0.04%	160
2018 Q2	$1.17M	Sell	96,464 -6,291	-6%	-$64.8K	0.06%	153
2018 Q1	$1.02M	Sell	102,755 -1,181	-1%	-$13.3K	0.04%	181
2017 Q4	$1.37M	Buy	103,936 +16,198	+18%	+$209K	0.05%	177
2017 Q3	$1.29M	Buy	+87,738	New	+$8.85M	0.05%	146

Other funds holding ARAV

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NTC

NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ascend Capital's ARAV Position: Q3 2018 in Review

Ascend Capital reduced its Aravive, Inc. Common Stock (ARAV) stake by 3.3% in Q3 2018, selling an estimated $34K and leaving 93,239 shares worth $783K. The position accounts for 0.04% of the portfolio, ranked #160.

Ascend Capital first reported a position in ARAV in Q3 2017 and has held it in 5 quarters since. The position peaked at $1.37M in Q4 2017. 50 funds tracked by Wall St. Rank hold ARAV as of Q3 2018.

Ascend Capital held 93,239 shares of Aravive, Inc. Common Stock worth $783K as of Q3 2018.
Ascend Capital sold 3,225 Aravive, Inc. Common Stock shares in Q3 2018, an estimated $34K.
Aravive, Inc. Common Stock made up 0.04% of Ascend Capital's portfolio in Q3 2018, its #160 holding.
Ascend Capital first reported a position in Aravive, Inc. Common Stock in Q3 2017 and has held it in 5 quarters since.
Ascend Capital's Aravive, Inc. Common Stock position peaked at $1.37M in Q4 2017.
50 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.